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Snapshot
IN OCTOBER 2000, a 10-year-old Aboriginal boy from the
Darwin region of the Northern Territory was referred to
hospital with a 24-hour history of abdominal pain, initially
generalised, but then localising to the right iliac fossa. The
pain was accompanied by occasional vomiting, but no fever
or diarrhoea was noted. At laparotomy, a gangrenous,
unruptured appendix was removed. Postoperatively, the
patient made  good recovery. Neither he nor any family
members had travelled outside the Northern Territory.
Histological sections of the surgical specimen showed
changes typical of acute suppurative appendicitis. Closer
examination, however, revealed numerous round-to-oval
structures resembling trophozoites (see Box). When the
possibility of invasive amoebiasis was raised, staining of the
section with Entamoeba histolytica-specific sera confirmed
the diagnosis. E. histolytica serology was negative.
Discussion
E. histolytica is a protozoan parasite of humans that causes
infectious colitis and amoebic liver abscess. It has recently
been recognised that invasive disease is caused exclusively by
the species E. histolytica, while the morphologically identical
species E. dispar exists in the colonic lumen as a harmless
saprophyte.1
Patients with invasive amoebiasis liv-
ing in Australia and other developed
countries generally acquire the infec-
tion outside their country in a region
where the pathogenic species is known
to be endemic. While cases of amoebi-
asis in Australians who have not trav-
elled overseas have been reported,2-6 all
except one pre-date the recognition of
pathogenic and non-pathogenic spe-
cies, and in none was the primary
source identified.
Isolated appendicitis due to E. histo-
lytica is a rare condition. Even in
regions where the organism is
endemic, it causes less than 1% of
cases of appendicitis.7
The diagnostic method of choice for
amoebic colitis is testing for parasite
antigen in stools.1 In this case, for the
first time, the species-specific antibody
normally used in the stool antigen test
was adapted for immunohistochemis-
try and confirmed E. histolytica infec-
tion. Possible alternative methods for
confirming the diagnosis include the
polymerase chain reaction (PCR) or
detection of E. histolytica-specific anti-
bodies or parasite antigen in patient
serum.1 However, PCR is not readily
available outside research laboratories.
The sensitivity of the E. histolytica antibody test in intestinal
disease is 52%, a likely explanation for the negative serolog-
ical test.
It is curious that no outbreaks of the readily identified and
much more common manifestations of this infection,
namely amoebic colitis and amoebic liver abscess, have been
recently reported in northern Australia.
The potential public health significance of a case of
proven autochthonous infection in an Australian population
is reinforced by its high transmissibility in settings where
hygiene may be suboptimal.8 Furthermore, there is a well
documented possibility of prolonged latency between infec-
tion and the development of invasive disease.1 Both these
factors support the merit of selective screening and appro-
priate treatment of at-risk contacts if invasive disease is
detected. The use of new diagnostic techniques, such as the
adapted staining method we used, will enable a more
accurate determination of the endemicity of E. histolytica in
Australia.
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Endemic invasive amoebiasis in northern Australia
Entamoeba histolytica in an inflamed 
appendix
A: Periodic acid–Schiff stain, showing tropho-
zoites (arrowed) within an inflammatory infiltrate.
B: Immunoperoxidase stain of trophozoites 
(arrowed) using E. histolytica-specific sera. 
Note the surrounding necrotic tissue.
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